Capital City Bank Group, Inc. Reports First Quarter 2025 Results
TALLAHASSEE, Fla., April 21, 2025 ( GLOBE NEWSWIRE ) -- Capital City Bank Group, Inc. ( NASDAQ: CCBG ) today reported net income attributable to common shareowners of $16.9 million, or $0.99 per diluted share, for the first quarter of 2025 compared to $13.1 million, or $0.77 per diluted share, ...
CECO Environmental to Release First Quarter Earnings and Host Conference Call on April 29 - CECO Environmental ( NASDAQ:CECO )
ADDISON, Texas, April 21, 2025 ( GLOBE NEWSWIRE ) -- CECO Environmental Corp. CECO, a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced that it will report its first quarter of 2025 financial ...
BIGBEAR.AI HOLDINGS, INC. ( NYSE: BBAI ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds BigBear.ai Holdings, Inc. Investors of Upcoming Deadline - BigBear.ai Hldgs ( NYSE:BBAI )
NEW YORK, April 21, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP: Do you, or did you, own shares of BigBear.ai Holdings, Inc. BBAI? Did you purchase your shares between March 31, 2022 and March 25, 2025, inclusive? Did you lose money in your investment in BigBear.ai Holdings, Inc.?
PX Energy, an Expanding Vertically Integrated Refinery and Mining Operation Located in Southern Brazil, Intends to Go Public Through a Business Combination with Papaya Growth Opportunity Corp. I, Including a Committed $10 Million Investment
TORONTO, April 21, 2025 ( GLOBE NEWSWIRE ) -- PX Energy ( "PX" or the "Company" ) , a vertically-integrated refined products manufacturer serving the Brazilian market for refined oil and agricultural grade products ( through its parent company, Forbes & Manhattan Resources Inc. ) , and Papaya ...
Ascentage Pharma Announces Inclusion of Lisaftoclax and Olverembatinib in Chinese Society of Clinical Oncology ( CSCO ) 2025 Guidelines
ROCKVILLE, Md. and SUZHOU, China, April 21, 2025 ( GLOBE NEWSWIRE ) -- Ascentage Pharma ( NASDAQ: AAPG. HKEX: 6855 ) , a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for hematological ...
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren's Disease ( SjD ) and Cutaneous Lupus Erythematosus ( CLE ) for IMVT-1402
NEW YORK, April 21, 2025 ( GLOBE NEWSWIRE ) -- Immunovant, Inc. ( Nasdaq: IMVT ) , a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced next phase of growth including changes to its leadership team and the expanded ...
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
NEW YORK, April 21, 2025 ( GLOBE NEWSWIRE ) -- OTC Markets Group Inc. ( OTCQX: OTCM ) , operator of regulated financial markets for 12,000 U.S. and global securities, today announced the first quarter 2025 performance and quarterly rebalancing of the OTCQX® indexes, including the OTCQX Canada ...
BioCryst to Report First Quarter 2025 Financial Results on May 5
RESEARCH TRIANGLE PARK, N.C., April 21, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq: BCRX ) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025.
